Turner Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Turner Investments’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-19,340	Closed	-$351K	–	304
2016 Q3	$351K	Sell	19,340 -52,080	-73%	-$1.02M	0.12%	157
2016 Q2	$1.18M	Sell	71,420 -84,640	-54%	-$1.37M	0.37%	83
2016 Q1	$2.59M	Sell	156,060 -209,080	-57%	-$3.66M	0.7%	47
2015 Q4	$7.91M	Sell	365,140 -275,790	-43%	-$5.37M	1.64%	5
2015 Q3	$12.7M	Buy	640,930 +227,340	+55%	+$7.18M	2.57%	1
2015 Q2	$14.4M	Sell	413,590 -68,500	-14%	-$2.09M	2.63%	1
2015 Q1	$12.5M	Sell	482,090 -17,044	-3%	-$312K	2.25%	1
2014 Q4	$6.43M	Sell	499,134 -858,284	-63%	-$10.7M	0.76%	23
2014 Q3	$16.7M	Buy	1,357,418 +592,729	+78%	+$6.89M	1%	12
2014 Q2	$12.1M	Buy	764,689 +500,715	+190%	+$7.15M	0.54%	33
2014 Q1	$3.99M	Buy	263,974 +115,564	+78%	+$1.31M	0.11%	233
2013 Q4	$1.13M	Buy	+148,410	New	+$800K	0.02%	471

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Turner Investments's HZNP Position: Q4 2016 in Review

Turner Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2016, closing a stake of 19,340 shares — an estimated $351K sold.

Turner Investments first reported a position in HZNP in Q4 2013 and held it in 12 quarters. The position peaked at $16.7M in Q3 2014. 234 funds tracked by Wall St. Rank hold HZNP as of Q4 2016.

Turner Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2016 after selling out during the quarter.
Turner Investments sold 19,340 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2016, an estimated $351K.
Turner Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 12 quarters.
Turner Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $16.7M in Q3 2014.
234 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2016.

Based on Turner Investments's 13F filing for Q4 2016, filed 8 Feb 2017.